| Autor: |
Katherine, Ahrens, Michael, Sharbaugh, Marian P, Jarlenski, Lu, Tang, Lindsay, Allen, Anna E, Austin, Andrew J, Barnes, Marguerite E, Burns, Sarah, Clark, Kara, Zivin, Aimee, Mack, Gilbert, Liu, Shamis, Mohamoud, Mary Joan, McDuffie, Lindsey, Hammerslag, Adam J, Gordon, Julie M, Donohue, Emelie, Bailey |
| Rok vydání: |
2022 |
| Zdroj: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. |
| ISSN: |
1537-6591 |
| Popis: |
Limited information exists about testing for HIV, HBV, and HCV among Medicaid enrollees after initiating an episode of medication treatment for opioid use disorder (MOUD), despite guidelines recommending such testing. Our objectives were to estimate testing prevalence and trends for HIV, HBV, and HCV among Medicaid enrollees initiating MOUD and examine enrollee characteristics associated with testing.We conducted a serial cross-sectional study of 505,440 initiations of MOUD from 2016 to 2019 among 361,537 Medicaid enrollees aged 12-64 years in 11 states. Measures of MOUD initiation; HIV, HBV, and HCV testing; comorbidities; and demographics were based on enrollment and claims data. Each state used Poisson regression to estimate associations between enrollee characteristics and testing prevalence within 90 days of MOUD initiation. We pooled state-level estimates to generate global estimates using random effects meta-analyses.From 2016 to 2019, testing for HIV increased from 20% to 25%, HBV from 22% to 25%, HCV from 24% to 27%, and for all three conditions from 15% to 19%. Adjusted rates of testing for all three conditions were lower among enrollees who were male (vs. non-pregnant females), living in a rural area (vs. urban area), and initiating methadone or naltrexone (vs. buprenorphine). Associations between enrollee characteristics and testing were heterogeneous across states.Among Medicaid enrollees in 11 states, testing for HIV, HBV, and HCV increased among enrollees initiating MOUD; however, approximately three-quarters of enrollees were not tested for each condition, and testing rates differed by enrollee characteristics. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
